GB1158456A - Preparations Containing Sugars - Google Patents
Preparations Containing SugarsInfo
- Publication number
- GB1158456A GB1158456A GB27167/67A GB2716767A GB1158456A GB 1158456 A GB1158456 A GB 1158456A GB 27167/67 A GB27167/67 A GB 27167/67A GB 2716767 A GB2716767 A GB 2716767A GB 1158456 A GB1158456 A GB 1158456A
- Authority
- GB
- United Kingdom
- Prior art keywords
- glucose
- phosphate
- compositions
- fructose
- emulsions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 235000000346 sugar Nutrition 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- 150000008163 sugars Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- 239000002585 base Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 abstract 1
- BIRSGZKFKXLSJQ-SQOUGZDYSA-N 6-Phospho-D-gluconate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O BIRSGZKFKXLSJQ-SQOUGZDYSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 abstract 1
- 229930091371 Fructose Natural products 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- 239000005715 Fructose Substances 0.000 abstract 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- -1 Na or K) Chemical class 0.000 abstract 1
- PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract 1
- HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 abstract 1
- 229930182830 galactose Natural products 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 229950010772 glucose-1-phosphate Drugs 0.000 abstract 1
- 229940045189 glucose-6-phosphate Drugs 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 229960005015 local anesthetics Drugs 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000001477 organic nitrogen group Chemical class 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 125000005270 trialkylamine group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB27167/67A GB1158456A (en) | 1967-06-13 | 1967-06-13 | Preparations Containing Sugars |
| FR140621A FR7346M (enExample) | 1967-06-13 | 1968-02-21 | |
| DE19681767743 DE1767743C (de) | 1967-06-13 | 1968-06-12 | Pharmazeutische Zusammensetzung auf der Basis von Zuckern |
| BE716529D BE716529A (enExample) | 1967-06-13 | 1968-06-13 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB27167/67A GB1158456A (en) | 1967-06-13 | 1967-06-13 | Preparations Containing Sugars |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1158456A true GB1158456A (en) | 1969-07-16 |
Family
ID=10255289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB27167/67A Expired GB1158456A (en) | 1967-06-13 | 1967-06-13 | Preparations Containing Sugars |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE716529A (enExample) |
| FR (1) | FR7346M (enExample) |
| GB (1) | GB1158456A (enExample) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2185398A (en) * | 1986-01-17 | 1987-07-22 | Foscama Biomed Chim Farma | Use of fructose-1,6-diphosphate to protect against the toxic effects of antitumour drugs |
| EP0249008A3 (en) * | 1986-05-09 | 1989-09-27 | Gerhard Prof. Dr. Med. Pulverer | Agent and process for the prevention of metastases of malignic tumours |
| WO1991009604A1 (en) * | 1989-12-21 | 1991-07-11 | Perstorp Ab | A pharmaceutical composition comprising a phosphosugar |
| EP0510687A3 (en) * | 1991-04-26 | 1993-05-12 | The Green Cross Corporation | Infusion preparation |
| US5626880A (en) * | 1991-04-26 | 1997-05-06 | The Green Cross Corporation | Infusion preparation |
| WO2003039556A1 (en) * | 2001-11-07 | 2003-05-15 | Ceretech Limited | Rehydrating formulation |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5654280A (en) * | 1989-12-21 | 1997-08-05 | Perstorp Ab | Pharmaceutical composition |
-
1967
- 1967-06-13 GB GB27167/67A patent/GB1158456A/en not_active Expired
-
1968
- 1968-02-21 FR FR140621A patent/FR7346M/fr not_active Expired
- 1968-06-13 BE BE716529D patent/BE716529A/xx unknown
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2185398A (en) * | 1986-01-17 | 1987-07-22 | Foscama Biomed Chim Farma | Use of fructose-1,6-diphosphate to protect against the toxic effects of antitumour drugs |
| GB2185398B (en) * | 1986-01-17 | 1990-06-13 | Foscama Biomed Chim Farma | Use of fructose-1,6-diphosphate to protect against the toxic effects of antitumour drugs |
| EP0249008A3 (en) * | 1986-05-09 | 1989-09-27 | Gerhard Prof. Dr. Med. Pulverer | Agent and process for the prevention of metastases of malignic tumours |
| WO1991009604A1 (en) * | 1989-12-21 | 1991-07-11 | Perstorp Ab | A pharmaceutical composition comprising a phosphosugar |
| GB2255280A (en) * | 1989-12-21 | 1992-11-04 | Perstorp Ab | A pharmaceutical composition comprising a phosphosugar |
| EP0510687A3 (en) * | 1991-04-26 | 1993-05-12 | The Green Cross Corporation | Infusion preparation |
| US5626880A (en) * | 1991-04-26 | 1997-05-06 | The Green Cross Corporation | Infusion preparation |
| US5674527A (en) * | 1991-04-26 | 1997-10-07 | The Green Cross Corporation | Infusion preparation comprising phospholipid |
| EP0671166A3 (en) * | 1991-04-26 | 1998-01-07 | The Green Cross Corporation | Nutrient-supplying preparation |
| EP0752243A3 (en) * | 1991-04-26 | 1998-01-07 | The Green Cross Corporation | Container filled with infusion liquids |
| US5972367A (en) * | 1991-04-26 | 1999-10-26 | The Green Cross Corporation | Infusion preparation |
| WO2003039556A1 (en) * | 2001-11-07 | 2003-05-15 | Ceretech Limited | Rehydrating formulation |
Also Published As
| Publication number | Publication date |
|---|---|
| BE716529A (enExample) | 1968-11-04 |
| FR7346M (enExample) | 1969-10-13 |
| DE1767743A1 (de) | 1971-09-30 |
| DE1767743B2 (de) | 1973-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2960769D1 (en) | Substituted 5.6-dimethylpyrrolo(2,3-d)pyrimidines, methods for their preparation and medicines containing them | |
| GB1070492A (en) | Sustained release tablets | |
| GB1158456A (en) | Preparations Containing Sugars | |
| CA934652A (en) | Upper row lock linkage | |
| GB1247801A (en) | Pharmaceutical compositions | |
| GB2018135A (en) | Pharmaceutical compositions containing ortho-aminobenzoic acid glycosides | |
| IE33207B1 (en) | Diazacarbazoles | |
| GB1049996A (en) | New medicine with anti-inflammatory and anti-rheumatic activity | |
| GB1203328A (en) | Pharmaceutical compositions | |
| ZA735753B (en) | Resolution of 6-substituted amino phenyl-2,3,5,6-tetrahydro(2,1-b)thiadiazoles | |
| GB1293329A (en) | Pharmaceutical compositions | |
| CA939938A (en) | Procede de preparation de poudres d'alliages | |
| IL33134A (en) | Pyrimidine derivatives,process for the preparation thereof and pesticidal compositions containing them | |
| CA769021A (en) | 9.beta.,10.alpha.-STEROIDS, METHODS OF PRODUCING SAID COMPOUNDS AND METHODS OF PRODUCING PHARMACEUTIC PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE CONSTITUENTS AND SAID PREPARATIONS | |
| JPS5283033A (en) | Memory diagnostic system | |
| GB842729A (en) | The tannic acid salt of 1-p-chlorobenzyl-2-pyrrolidylmethylbenzimidazole and medicinal preparations containing the same | |
| EP0000473B1 (en) | Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives | |
| GB1239881A (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING beta-RECEPTOR BLOCKING AGENTS AND CARDIAC GLYCOSIDES | |
| Tomasia et al. | Chemical composition of fluorine-free titanium enamels on anatase-rutile crystal formation | |
| GB1257711A (enExample) | ||
| GB2157690B (en) | Bornane derivatives | |
| GB1246649A (en) | Thiazole derivatives and compositions containing such compounds | |
| GB1244437A (en) | Improvements in or relating to a dioxolan derivative and its use in pharmaceutical preparations | |
| CA804582A (en) | PHARMACEUTICAL PREPARATIONS CONTAINING .alpha.-AMINO-.beta.-(3:4-DICHLOROPHENYL)-BUTYRIC ACID, OR ITS SALTS | |
| JPS53116039A (en) | System controller |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |